Detalles de la búsqueda
1.
The Validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD): The development and reliability testing of a novel clinical outcome measurement instrument for the severity of atopic dermatitis.
J Am Acad Dermatol
; 83(3): 839-846, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-32344071
2.
Comprehensive Assessment of Pharmacokinetics, Pharmacodynamics, and Tolerability of Ligelizumab in Healthy Volunteers and Patients with Chronic Spontaneous Urticaria to Optimize Its Subcutaneous Delivery System.
Pharmaceutics
; 15(9)2023 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37765235
3.
Ligelizumab improves sleep interference and disease burden in patients with chronic spontaneous urticaria.
Clin Transl Allergy
; 12(2): e12121, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-35218324
4.
A structural annotation resource for the selection of putative target proteins in the malaria parasite.
Malar J
; 7: 90, 2008 May 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-18500983
5.
Open-Label, Phase II Study to Assess the Efficacy and Safety of Canakinumab Treatment in Active Hyperimmunoglobulinemia D With Periodic Fever Syndrome.
Arthritis Rheumatol
; 69(8): 1679-1688, 2017 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-28482144
Resultados
1 -
5
de 5
1
Próxima >
>>